Itzchak Angel

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel

Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel.

Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel.